Story Timeline
Who reported a story first, and how coverage spread across the spectrum.
A CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo
1 articles over 1 hours.
First unratedNaturefirst overall
- NatureNo political leanA CD7-targeted AAV variant enables efficient T and NK cell engineering in vivo
How this was worked out
Every article INDB grouped into this story, in the order the outlets published them (times in UTC, from the outlets' feeds).
How INDB scores stories · Data: stories INDB grouped from the outlets on the sources page.